4th Quarter - Report

NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2010 $70,000 Replaced
4th Quarter - Amendment Jan 20, 2010 $70,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

"Medicare Part D Cost Sharing Assistance Act of 2009" Medicare Part D "doughnut hole" Medicare Physician Reimbursement and Medicaid reimbursement rates for primary care Medicare two-year waiting period

LobbyistCovered position, as disclosed
GRAYSON FOWLER —
AMY WOTRING —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Tobacco TOB

Coverage of Comprehensive Tobacco Cessation Services for Pregnant Women in Medicaid, FDA regulation of tobacco

LobbyistCovered position, as disclosed
GRAYSON FOWLER —
AMY WOTRING —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Labor HHS Appropriations: appropriations levels for NIH, NCI, CDC, and AHRQ Labor HHS Appropritations: appropriations for Patient Advocate Foundation VCUP Agriculture Appropriations: appropriations level for FDA

LobbyistCovered position, as disclosed
GRAYSON FOWLER —
AMY WOTRING —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

"Cancer Drug Coverage Parity Act of 2009" (HR 2366) "Comprehensive Cancer Care Improvement Act" (HR 1844 & S. 1773) "Affordable Access to Prescription Medications Act of 2009" (HR 3799) "Women's Health Amendment", atrial fibrillation

LobbyistCovered position, as disclosed
GRAYSON FOWLER —
AMY WOTRING —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1773 (111th), H.R. 3799 (111th), H.R. 1844 (111th), H.R. 2366 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.